Eastwest Bioscience Inc. Reports Earnings Results for the Third Quarter Ended April 30, 2020
EastWest Bioscience Inc. announced earnings results for the third quarter ended April 30, 2020. For the third quarter, the company announced total revenue was CAD 138,685 compared to CAD 478,692 a year ago. Net loss was CAD 374,690 compared to CAD 828,045 a year ago. Basic eps - continuing operations was CAD 0 compared to basic loss per share from continuing operations of CAD 0.01 a year ago. For the nine months, total revenue was CAD 794,576 compared to CAD 915,681 a year ago. Net loss was CAD 841,062 compared to CAD 2.430 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.03 a year ago.